Visanu Thamlikitkul
About
In The Last Decade
Visanu Thamlikitkul
201 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Molecular Medicine 3.4k
- Epidemiology 2.5k
- Pharmacology 2.2k
- Applied Microbiology and Biotechnology 1.3k
- Infectious Diseases 718
Countries citing papers authored by Visanu Thamlikitkul
This map shows the geographic impact of Visanu Thamlikitkul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Visanu Thamlikitkul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Visanu Thamlikitkul more than expected).
Fields of papers citing papers by Visanu Thamlikitkul
This network shows the impact of papers produced by Visanu Thamlikitkul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Visanu Thamlikitkul. The network helps show where Visanu Thamlikitkul may publish in the future.
Co-authorship network of co-authors of Visanu Thamlikitkul
This figure shows the co-authorship network connecting the top 25 collaborators of Visanu Thamlikitkul. A scholar is included among the top collaborators of Visanu Thamlikitkul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Visanu Thamlikitkul. Visanu Thamlikitkul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | Comparative Effectiveness and Safety of Original Gabapentin and Generic Gabapentin in Treating Patients with Neuropathic Pain at Siriraj Hospital, Bangkok, Thailand | 1 |
| 7 | Monitoring of Effectiveness and Safety of Colistin for Therapy in Resistant Gram-Negative Bacterial Infections in Hospitalized Patients at Siriraj Hospital. | 11 |
| 8 | Accuracy of ICD-10 Coding System for Identifying Comorbidities and Infectious Conditions Using Data from a Thai University Hospital Administrative Database. | 9 |
| 9 | Implementation of antibiotic use guidelines for fresh traumatic wound at Siriraj Hospital. | 4 |
| 10 | STOP Antimicrobial Resistance: Everybody’s Business | 3 |
| 11 | Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital. | 3 |
| 12 | Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections. | 18 |
| 13 | 19 | |
| 14 | Microbiological equivalence of bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving generic piperacillin/tazobactam (Pipertaz) and original piperacillin/tazobactam (Tazocin). | 1 |
| 15 | Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital. | 6 |
| 16 | Microbiological equivalence of serum bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving original meropenem (Meronem) and generic meropenem (Mero). | 2 |
| 17 | 95 | |
| 18 | Effectiveness of the Royal Thai Traditional Massage for Relief of Muscle Pain | 2 |
| 19 | Clinical Study of Morus Alba Linn. on Glycemic Control and Blood Lipids in Patients with Type 2 Diabetes: A Preliminary Study | 2 |
| 20 | Use of Alternative Medicines among Medical Patients at Siriraj Hospital | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.